Amman Stock Market Falls    Russia Reports 6,431 New Coronavirus Cases, 150 Deaths    HRH Crown Prince Congratulates President of Guinea-Bissau on Independence Day    Saudi Press: Saudi Arabia Celebrates 90th Anniversary of its National Day With Comprehensive Development    Weather Forecast for Wednesday    Land of the future Saudi Arabia celebrates its 90th National Day with a proud history and bright future    Saudi Cabinet calls for confronting Iran's destabilizing behavior    Saudi Arabia allows gradual resumption of Umrah from Oct. 4    Al-Qasabi lauds efforts of trade and investment working group    HyperX releases first Arabic layout keyboard for gaming    Riyadh Ranks the 5th Smart City among G20 Member States' Capitals, on IMD Indicator    Saudi Arabia's National Day holds exceptional significance for Yemenis    BAB confirms banks' readiness to defer loan installments    Happy National Day 90    Global oil & gas project sanctioning is set to recover and exceed pre-COVID-19 levels from 2022    Roma given defeat by Serie A for using ineligible player    Sotheby's, Phillips and Ketterer adapt to the new reality    Custodian of the Two Holy Mosques Receives Cables of Congratulations on the Kingdom's 90th National Day from Rulers of Fujairah, Oum Al-Quwain, Sharjah, Ras Al-Khimah & Ajman    Health officials get first dose of COVID-19 vaccine    UAE nuclear energy plant Unit 1 reaches 50% power capacity    Kingdom to mark 90th National Day with pride    India's new COVID-19 cases at lowest in almost a month    Saudi Arabia continues to work toward achieving peace in Yemen: Prince Khalid    AL Secretary General Meets with Arab Parliament's Speaker    50 riders to take part in National Day show jumping competition    Amman Stock Market Falls    Abu Dhabi, Israel, forge film ties following peace accord    AlUla Date Festival to Launch Next Month    Bahrain Bourse Falls    Air show, fireworks planned for 90th Saudi National Day    My goal is to lift the national football cup: Maram    SGS Signs MoU to Use Best Technologies in Sterilizing Planes and Airports in Saudi Arabia    SAGO Completes Procedures for 6th Barley Tender in 2020    UAE Team Emirates' Pogacar wins the Tour De France    New expat body to help women, kids tackle pandemic trauma    Every work has its fruits, so choose wisely    Wydad appeal over CAF 2019 Champions' final dismissed by CAS    Saudi Youths Transfer Saudi Arabia's Culture via Animation Production    Saudi Scholarship Program to Promote Football Talents, abroad, Co-sign Accord with Spanish Real Sociedad    French Open to allow 11,500 fans per day between the three show courts    Saudi Films' Festival virtual Events Continued    Saudi Films' Festival Events Continue, amid Wide-Scale Cultural Participation    Mediation center contributes to 22% decrease in divorces    Saudi woman seeks to restrain wealthy hubby from remarrying    Eid Al-Adha Prayer Performed at the Grand Holy Mosque    Pilgrims Perform Dhuhr and Asr Prayers in Arafat Holy Site    Senior Scholars Council Issues Decision No. 246 Regarding Attendance of Friday Prayer and Prayers at Mosques in a Case of Spread of Epidemic or Fear of its Spread    Custodian of the Two Holy Mosques Addresses Citizens and Muslims on Eid Al-Fitr    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





G42 Healthcare partners with WHOOP to enhance volunteer experience
Published in The Saudi Gazette on 14 - 08 - 2020

Abu Dhabi-based G42 Healthcare has announced a volunteer healthcare management program with Boston-based wearable technology firm WHOOP. The partnership will offer volunteers participating in the world's first Phase III trials of an COVID-19 vaccine the opportunity to benefit from a 24/7 fitness and health monitor to measure key biometrics. This is the first trial of its kind to feature wearable technology and will include thousands of volunteers who are participating in the trials.
The Whoop4Humanity initiative ensures that volunteers who now join the clinical trials at ADNEC in Abu Dhabi and the Al Qarain Center in Sharjah, including those coming in for the second dose, can further enhance their volunteer journey by using the new wearable devices which will enable them to check their daily heart rate, respiratory rate, heart rate variability, sleep performance, and more.
Commenting on the new partnership, G42 Healthcare CEO Ashish Koshy said: "As a digital business, this new partnership is a logical extension of the highly-advanced AI and super computer solutions we are already using in the trials process. New volunteers will be invited to engage with the technology developed by WHOOP that will enhance their individual volunteer experience.
"We believe that giving volunteers an opportunity to use the WHOOP Strap 3.0 wearable device will reinforce their confidence in the trial by giving them the ability to check on several daily health data points. This will complement the world-class clinical expertise that the healthcare professionals in the UAE are providing to the volunteers and ensure their safety and well-being throughout the trials process."
G42 Healthcare believes that WHOOP can be a powerful tool to boost the comprehensive volunteer healthcare management program by helping thousands of vaccine volunteers to self-monitor their well-being while measuring their fitness, sleep, and recovery levels during the trials. WHOOP provides valuable insights and actionable feedback around specific markers, thus encouraging better decision making for volunteers' health.
"WHOOP is proud to partner with G42 Healthcare and participate in their innovative Phase III COVID-19 vaccine trial," said Will Ahmed, WHOOP Founder & CEO.
"The continuous biometric monitoring offered by WHOOP will help volunteers evaluate any changes to their health and help track their daily fitness levels. This partnership represents the future of healthcare: using continuous monitoring and artificial intelligence to better understand the effect of drugs, vaccines, and other treatments."
WHOOP uniquely blends hardware, software, and industry-leading accurate measurements to help people sharpen the edges of performance, create impactful behavior change and a new set of positive individual habits, and empower them to optimize all facets of life.
The trials began in Abu Dhabi on July 16 and are being managed by G4 Healthcare in partnership with the Department of Health - Abu Dhabi, the UAE Ministry of Health and Prevention (MOHAP) and Abu Dhabi Health Services Company (SEHA). They are being conducted following the international guidelines stipulated by the World Health Organization (WHO) and the United States Food & Drug Administration (USFDA).
The Phase III clinical trials follow the success of the Phase I and Phase II trials conducted by Sinopharm in China, which resulted in 100% of the volunteers generating antibodies to SARS-CoV-2, the virus that causes COVID-19, after two doses in 28 days. The Phase III trials are open to individual volunteers aged between 18 and 60 living in the UAE and Bahrain and will last for six to 12 months, with the volunteers required to be available for follow ups during this time. — SG


Clic here to read the story from its source.